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N-Sulfanylethylanilide-based traceable linker for enrichment and 
selective labelling of target proteins 
Takuya Morisaki, a Masaya Denda,a Jun Yamamoto,a Daisuke Tsuji,b Tsubasa Inokuma,a Kohji Itoh,b 
Akira Shigenaga,*ac and Akira Otaka*a
An N-sulfanylethylanilide-based traceable linker, developed to 
facilitate identification of target proteins of bioactive compounds, 
was introduced into an alkynylated target protein. Subsequent 
adsorption onto streptavidin beads allowed it to be treated with a 
cysteine-fluorophore conjugate in the presence of phosphate. This 
induced the N-S acyl transfer reaction of the N-sulfanylethylanilide 
unit. The subsequent native chemical ligation of the fluorophore 
resulted in cleavage of the linker for target elution and fluorescent 
labelling of the target, allowing it to be distinguished from non-
target proteins. 
Many bioactive ligands such as natural products and synthetic 
small molecules exhibit their biological activity via the 
formation of specific binding interactions with their target 
proteins such as enzymes, receptors and ion channels. The 
unambiguous identification of the target proteins involved in 
these ligand-mediated biological processes is therefore 
essential for targeted drug development and chemical biology 
research to clarify the biological signalling pathways affected 
by the binding of such ligands. Target proteins are generally 
identified as follows: (1) the attachment of a tag moiety to the 
target protein using a suitably functionalized ligand; (2) tag-
based enrichment of the target; and (3) sequence analysis of 
the target protein using proteomics, Edman degradation 
and/or mass spectrometry (MS).1 The first steps generally 
involves the covalent attachment of a tag moiety (e.g., an 
alkyne), which is usually achieved by photo-affinity labelling 
using a photo-irradiation1a,b,2 or activity-based probe approach 
involving a chemical reaction.1c-e The tagged target protein can 
then be connected to a biotinylated linker molecule for 
purification over streptavidin beads based on the strong 
biotin-streptavidin interaction.1,3 The subsequent release of 
the target protein from the streptavidin beads is then required 
for sequence analysis. However, this process can be hampered 
by the high strength of the biotin-streptavidin interaction (Kd = 
10-15 M),4 and several cleavable linker molecules have 
therefore been developed to overcome this issue. The use of a 
cleavable linker for the efficient elution of a target protein 
from streptavidin beads has been successfully applied.5 
However, this use can sometimes result in contamination of 
the target protein with non-target materials derived from non-
specific adsorption processes.6 Contamination of the target in 
this way can hamper its subsequent identification and several 
research groups, including our own, have recently reported 
the development of traceable linkers as advanced cleavable 
systems for the selective labelling of target proteins. In this 
way, it is possible to discriminate the target protein from non-
target materials.7 Cleavage of the traceable linker leads to the 
formation of an orthogonal functional group that is not seen in 
the non-target proteins. This orthogonal functional group can 
then be selectively labelled with a reporter unit such as an 
isotopically-enriched probe or fluorescent dye that can 
contribute to its identification by MS or sodium dodecyl sulfate 
(SDS)-PAGE analysis, respectively. Previously reported 
traceable linkers are based on reversible reactions, including (i) 
hydrazone/hydrazone7e and hydrazone/oxime7d exchange 
reactions for linker cleavage and labelling; and (ii) oxime 
formation between an aldehyde-based reporter and an 
aminoxy group-containing cleavage product or vice versa.7a-c 
The oxyme and hydrazone linkage is stable under carefully 
optimized conditions.7d But more robust linkage that can be 
applicable to various working conditions without optimization 
is preferred to remove the potential risk of the linker being 
accidentally cleaved and/or the reporter being removed. The 
cleavage of the linker or the removal of the reporter would 
lead to a decreased detection limit of the analytical method. It 
was therefore envisioned that the development of a traceable 
linker capable of the cleavage and introduction of a suitable 
reporter via an irreversible reaction would represent an 
effective analytical tool. Herein, we report the development of 
an N-sulfanylethylanilide (SEAlide)-based traceable linker that 
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can be used to connect a target protein to a reporter unit via 
the formation of a stable amide bond. 
 
 
Scheme 1 Design of the SEAlide-based traceable linker. A) Phosphate 
catalysed activation of the SEAlide unit via N–S acyl transfer followed 
by NCL with a cysteinyl peptide; B) Enrichment and selective labelling 
of a target protein using the SEAlide-based traceable linker. 
 
 We previously reported the SEAlide unit as a precursor for 
C-terminal peptide thioester to be used in chemical protein 
synthesis (Scheme 1A).8 Peptide 1 bearing an amide-type 
SEAlide unit remained stable in the absence of phosphate, 
whereas the addition of phosphate led to its activation to give 
thioester 2.9 In situ generated 2 was subsequently reacted 
with a peptide bearing an N-terminal cysteine residue to give 
the amide-linked peptide 3 via native chemical ligation (NCL).10 
We envisaged that the cleavage of the SEAlide unit from 
peptide 1 followed by an amide-bond forming reaction with an 
N-cysteinyl peptide could be used to generate an irreversible 
traceable linker. 
With this in mind, we designed a SEAlide-based traceable 
linker consisting of a SEAlide unit attached to an azide group 
and biotin (Scheme 1B). In this study, the thiol moiety on the 
SEAlide unit was protected as StBu disulfide, which could be 
removed under the NCL conditions to avoid any complications 
resulting from disulfide formation or the accidental cleavage of 
the linker. The subsequent copper(I)-catalyzed alkyne-azide 
cycloaddition (CuAAC)11 reaction of the linker with an 
alkynylated target protein in the proteome would give 
conjugate 4, which could be enriched over streptavidin beads. 
The NCL of the molecules of 4 immobilized on the beads with 
the cysteine-derived reporter unit 5 in the presence of 
phosphate would allow for the elution of the amide-connected 
target protein-reporter conjugate via the removal of the StBu 
group and the subsequent cleavage of the linker. SEAlide-
based traceable linker 6 shown in Fig. 1 was prepared using 
Fmoc-based solid phase peptide synthesis (Fmoc SPPS) 
(Scheme S1). Prior to using this linker with a protein, we 
investigated its CuAAC reaction with the alkynylated small 
molecule S5,12 followed by the cleavage of the linker with 
cysteine to give the desired products, as shown in Fig. S1. We 
then proceeded to investigate the reaction of traceable linker 
6 with an alkynylated bovine serum albumin (BSA), which was 
used as a model alkynylated target protein.7a The CuAAC of 
traceable linker 6 and the alkynylated BSA afforded the 
corresponding biotinylated BSA, as shown in Fig. S2. The 
product was subsequently adsorbed on streptavidin beads and 
its elution was evaluated. In the presence of 1 M phosphate 
and 100 μM cysteine-fluorescein conjugate 8,13 successful 
elution of the fluorescently labelled BSA was observed as 
shown in Figure S3. Effect of concentration of phosphate on 
the elution efficiency was next examined, and efficient elution 
was observed when 400 mM phosphate was employed. When 
the resin obtained after the linker cleavage was boiled in the 
sample buffer, we detected a weak (400 or 100 mM 
phosphate) or moderate (1000 mM phosphate) fluorescence 
signal. This signal might be attributed to the labelled BSA that 
was adsorbed on the streptavidin beads through non-specific 
interactions because high concentration of phosphate can 
induce salting out of proteins. Next, the traceable linkers S8 
and S9, their linker length between the SEAlide and the azide is 
different to that of 6, were also examined but their elution 
efficiency was similar to that of original 6 (Fig. S4). Similar 
elution conditions were also applied to the product resulting 
from the CuAAC reaction of the model alkynylated BSA with 
the S-alkylated negative control 7, which could not be cleaved 
via an N-to-S acyl transfer reaction (Fig. 1 and S5). In this case, 
small amount of the protein was eluted from the beads, 
presumably because of the SDS-mediated denaturation of 
streptavidin. However, elution efficiency of the negative 
control was lower than that of the corresponding traceable 
linker 6. These results therefore demonstrate that linker 6 may 
be used to achieve an efficient elution profile by the cleavage 
of the linker. Furthermore, the eluted protein was detected by 
fluorescent imaging when 6 but not 7 was used as the linker.14 
 
 
Fig. 1 Structures of the SEAlide-based traceable linker 6, negative 
control 7, which could not be cleaved via thioester formation, and 
cysteine-fluoresceine conjugate 8. 
 
 Finally, we examined the enrichment and selective 
visualization of the alkynylated protein using a mixture of the 
alkynylated BSA and red blood cell lysate (Fig. 2). This mixture 
was treated with traceable linker 6, allowing for the CuAAC 
reaction. The resulting mixture was then treated with 
streptavidin beads, and the adsorbed proteins were eluted. 
The eluted mixture was analysed by SDS-PAGE and the 
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proteins were visualized by silver staining or fluorescent 
imaging. When the elution was performed by the denaturation 
of streptavidin in a similar manner to that used with 
conventional linkers, the enrichment of the BSA was observed 
(Fig. 2, silver staining, lane 4). The elution of the proteins by 
the cleavage of the linker in the presence of cysteine-
fluorescein conjugate 8 gave slightly better enrichment results 
compared with those obtained by the denaturation of 
streptavidin (Fig. 2, silver staining, lane 5). The traceable 
linker allowed for the visualization of the target, which could 
be used to identify specific targets (Fig. 2, fluorescence 
imaging, lane 5). When traceable linker 8 was applied to 
enrichment and labelling of the alkynylated BSA in lysate of 
HCT116 cells, contamination of the target with non-target 
proteins was observed but the target selective labelling 
enabled discrimination between the target and non-target 
materials (Fig. S7). 
 In conclusion, we have developed a SEAlide-based 
traceable linker as an advanced cleavable linker for the 
identification of specific protein targets. This new system not 
only allowed for the cleavage of the linker and the enrichment 
of the target in a similar manner to conventional cleavable 
linkers, but also allowed for the selective labelling of the target. 
In this way, it was possible to distinguish the desired target 
from any undesired non-target proteins. The results obtained 
in this study therefore demonstrate that this newly developed 
SEAlide-based traceable linker could be used for the facile 
identification of the target proteins of bioactive compounds, 
including drug candidates. Work toward the application of this 
traceable linker to identify the targets of target-unknown 
bioactive compounds is currently in progress. 
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Fig. 2 Enrichment and selective labelling of the alkynylated BSA in red 
blood cell lysate using traceable linker 6. Details of the conditions are 
shown in the supporting information. Lane 1: alkynylated BSA; Lane 2: 
red blood cell lysate; Lane 3: a mixture of the alkynylated BSA and red 
blood cell lysate; Lane 4: eluted proteins after the CuAAC reaction of 
the mixture with 6, adsorption of the biotinylated material onto 
streptavidin beads and the treatment of the beads with sample buffer 
at 100 °C for 5 min (elution by denaturation of streptavidin); Lane 5: 
eluted proteins after the CuAAC reaction of the mixture with 6, 
adsorption of the biotinylated material onto streptavidin beads and 
the treatment of the beads with cysteine-fluorescein conjugate 8 in 
the presence of phosphate (elution conditions: 100 μM 8, 50 mM 
MPAA, 40 mM TCEP, 0.1% SDS, 400 mM Na phosphate buffer, pH 7.4, 
37 °C, 24 h); Fluorescence imaging, λex = 460 nm, λem > 515 nm. 
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